CIK 0000200406
- Large accelerated filer
JOHNSON & JOHNSON
Sign in to watch- Ticker
- JNJ
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Jan 3
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221024240
- Phone
- +1 732-524-2455
- Business address
- ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
- Former names
- JOHNSON & JOHNSON ET AL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,947,986
- in 2 filings
Net −$12,947,986. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-10 | Broadhurst Vanessa EVP, Global Corp Affairs | Shares withheld for taxes | −597 | $162.08 | $97K | 16,662 |
| 2023-02-10 | Broadhurst Vanessa EVP, Global Corp Affairs | Exercise or conversion · Restricted Share Units | −1,592 | 0 | ||
| 2023-02-10 | Fasolo Peter Exec VP, Chief HR Officer | Exercise or conversion | +2,078 | 116,754.01 | ||
| 2023-02-10 | Fasolo Peter Exec VP, Chief HR Officer | Shares withheld for taxes | −761 | $162.08 | $123K | 115,993.01 |
| 2023-02-10 | Fasolo Peter Exec VP, Chief HR Officer | Exercise or conversion · Restricted Share Units | −2,078 | 0 | ||
| 2023-02-10 | Swanson James D. | Exercise or conversion | +1,291 | 8,355 | ||
| 2023-02-10 | Swanson James D. | Shares withheld for taxes | −388 | $162.08 | $63K | 7,967 |
| 2023-02-10 | Swanson James D. | Exercise or conversion · Restricted Share Units | −1,291 | 0 | ||
| 2023-01-17 | Gorsky Alex Director | Exercise or conversion | +547,692 | $72.54 | $39.7M | 1,133,193.67 |
| 2023-01-17 | Gorsky Alex Director | Shares withheld for taxes | −366,610 | $173.43 | $63.6M | 766,583.67 |
| 2023-01-17 | Gorsky Alex Director | Exercise or conversion · Employee Stock Options (Right to Buy) | −547,692 | $72.54 | $39.7M | 0 |
| 2023-01-17 | Duato Joaquin CEO and Chairman of the Board | Exercise or conversion | +148,538 | $72.54 | $10.8M | 394,515 |
| 2023-01-17 | Duato Joaquin CEO and Chairman of the Board | Shares withheld for taxes | −98,795 | $173.43 | $17.1M | 295,720 |
| 2023-01-17 | Duato Joaquin CEO and Chairman of the Board | Exercise or conversion · Employee Stock Options (Right to Buy) | −148,538 | $72.54 | $10.8M | 0 |
| 2022-12-13 | Wolk Joseph J Exec VP, CFO | Exercise or conversion | +12,926 | $90.44 | $1.2M | 48,738.2 |
| 2022-12-13 | Wolk Joseph J Exec VP, CFO | Exercise or conversion | +1,855 | $72.54 | $135K | 50,593.2 |
| 2022-12-13 | Wolk Joseph J Exec VP, CFO | Sale | −1,855 | $179.46 | $333K | 48,738.2 |
| 2022-12-13 | Wolk Joseph J Exec VP, CFO | Sale | −12,926 | $179.62 | $2.3M | 35,812.2 |
| 2022-12-13 | Wolk Joseph J Exec VP, CFO | Exercise or conversion · Employee Stock Options (Right to Buy) | −1,855 | 0 | ||
| 2022-12-13 | Wolk Joseph J Exec VP, CFO | Exercise or conversion · Employee Stock Options (Right to Buy) | −12,926 | 0 |
Page 39 of 60 · 1,189 trades